CymitQuimica logo

CAS 1236858-52-8

:

FHBANDDJQJAZOQ-CQSZACIVSA-N

Description:
The chemical substance with the name "FHBANDDJQJAZOQ-CQSZACIVSA-N" and CAS number "1236858-52-8" is a specific compound that may not be widely characterized in standard chemical databases. However, compounds with such identifiers typically belong to a class of organic molecules that may exhibit unique structural and functional properties. Characteristics of such substances can include their molecular formula, which dictates the types and numbers of atoms present, and their stereochemistry, which influences their reactivity and interaction with biological systems. Additionally, these compounds may have specific physical properties such as melting and boiling points, solubility in various solvents, and spectral characteristics that can be analyzed using techniques like NMR, IR, or mass spectrometry. The biological activity, if any, would depend on the functional groups present and their arrangement within the molecular structure. For detailed information, including safety data and potential applications, consulting specialized chemical literature or databases would be necessary.
Formula:C21H25N5O3
Synonyms:
  • 4H-Pyrazolo[3,4-d]pyrimidin-4-one, 1,5-dihydro-6-[(1R)-1-(3-phenoxy-1-azetidinyl)ethyl]-1-(tetrahydro-2H-pyran-4-yl)-
  • FHBANDDJQJAZOQ-CQSZACIVSA-N
  • PF 04449613,PF04449613
  • PF-04449613 >=98% (HPLC)
  • 1,5-Dihydro-6-[(1R)-1-(3-phenoxy-1-azetidinyl)ethyl]-1-(tetrahydro-2H-pyran-4-yl)-4H-pyrazolo[3,4-d]pyrimidin-4-one
  • PF-04449613
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 1 products.
  • PF 04449613
    Biosynth
    + Info

    PF 04449613

    CAS:
    <p>PF 04449613 is a drug that has been shown to be effective in the treatment of inflammatory bowel disease (IBD). It selectively inhibits cyclic nucleotide phosphodiesterases, which are enzymes that regulate the production of cyclic nucleotides. PF 04449613 regulates blood pressure and pro-inflammatory factors by inhibiting cAMP phosphodiesterase and cGMP phosphodiesterase. This mechanism may contribute to its efficacy in IBD as it reduces inflammation. PF 04449613 has also been shown to be effective in reducing camp levels in heart cells, which may reduce the risk of cardiac failure. PF 04449613 is being investigated for potential use in other conditions such as cancer and diabetes mellitus.</p>
    Formula:C21H25N5O3
    Purity:Min. 95%
    Molecular weight:395.45 g/mol

    Ref: 3D-LZB85852

    25mg
    894.00€
    50mg
    1,173.00€
    100mg
    1,876.00€